Cargando…
2282. Empiric Antimicrobial Therapy and Clinical Outcomes of Infections due to ESBL-producing Klebsiella pneumoniae
BACKGROUND: Currently, carbapenems are the treatment of choice for invasive infection due to extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL-E). However, clinical data supporting this practice are generated largely from cases caused by ESBL-producing Escherichia coli. We aimed to de...
Autores principales: | Wendy Fujita, Ayako, Clarke, Lloyd, Kusztos, Amanda E, Doi, Yohei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810055/ http://dx.doi.org/10.1093/ofid/ofz360.1960 |
Ejemplares similares
-
Ventilator touchscreen as source of ESBL-producing Klebsiella pneumoniae outbreak
por: Narciso, A, et al.
Publicado: (2011) -
Prevalence of ESBL-Producing Klebsiella pneumoniae Isolates in Tertiary Care Hospital
por: Sarojamma, Vemula, et al.
Publicado: (2011) -
ESBL-Producing Strain of Hypervirulent Klebsiella pneumoniae K2, France
por: Surgers, Laure, et al.
Publicado: (2016) -
mcr-1 Colistin Resistance in ESBL-Producing Klebsiella pneumoniae, France
por: Caspar, Yvan, et al.
Publicado: (2017) -
Antimicrobial susceptibility and genetic similarity of ESBL-positive Klebsiella pneumoniae strains
por: Sękowska, Alicja, et al.
Publicado: (2012)